OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
11.95
-0.25 (-2.05%)
At close: May 20, 2025, 4:00 PM
11.74
-0.21 (-1.76%)
After-hours: May 20, 2025, 7:37 PM EDT
OptimizeRx Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for OptimizeRx stock ranges from a low of $5.00 to a high of $16. The average analyst price target of $10.38 forecasts a -13.14% decrease in the stock price over the next year.
Price Target: $10.38 (-13.14%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for OptimizeRx stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $8 → $13 | Strong Buy | Maintains | $8 → $13 | +4.60% | May 13, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $11 → $14 | Buy | Maintains | $11 → $14 | +17.15% | May 13, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $8 | Buy | Reiterates | $8 | -33.05% | Feb 6, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $7 → $6 | Buy → Hold | Downgrades | $7 → $6 | -49.79% | Jan 8, 2025 |
| Lake Street | Lake Street | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | -7.95% | Dec 24, 2024 |
Financial Forecast
Revenue This Year
104.89M
from 92.13M
Increased by 13.85%
Revenue Next Year
116.58M
from 104.89M
Increased by 11.15%
EPS This Year
0.42
from -1.10
EPS Next Year
0.63
from 0.42
Increased by 48.74%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 110.6M | 127.3M |
| Avg | 104.9M | 116.6M |
| Low | 98.3M | 106.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 20.1% | 21.4% |
| Avg | 13.9% | 11.1% |
| Low | 6.7% | 1.8% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 0.60 | 0.84 |
| Avg | 0.42 | 0.63 |
| Low | 0.33 | 0.48 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | 98.1% |
| Avg | - | 48.7% |
| Low | - | 13.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.